These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 26230954

  • 1. PD-1(hi)TIM-3(+) T cells associate with and predict leukemia relapse in AML patients post allogeneic stem cell transplantation.
    Kong Y, Zhang J, Claxton DF, Ehmann WC, Rybka WB, Zhu L, Zeng H, Schell TD, Zheng H.
    Blood Cancer J; 2015 Jul 31; 5(7):e330. PubMed ID: 26230954
    [Abstract] [Full Text] [Related]

  • 2. T cell exhaustion characterized by compromised MHC class I and II restricted cytotoxic activity associates with acute B lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation.
    Liu L, Chang YJ, Xu LP, Zhang XH, Wang Y, Liu KY, Huang XJ.
    Clin Immunol; 2018 May 31; 190():32-40. PubMed ID: 29477343
    [Abstract] [Full Text] [Related]

  • 3. Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in mice.
    Talvard-Balland N, Braun LM, Dixon KO, Zwick M, Engel H, Hartmann A, Duquesne S, Penter L, Andrieux G, Rindlisbacher L, Acerbis A, Ehmann J, Köllerer C, Ansuinelli M, Rettig A, Moschallski K, Apostolova P, Brummer T, Illert AL, Schramm MA, Cheng Y, Köttgen A, Duyster J, Menssen HD, Ritz J, Blazar BR, Boerries M, Schmitt-Gräff A, Sariipek N, Van Galen P, Buescher JM, Cabezas-Wallscheid N, Pahl HL, Pearce EL, Soiffer RJ, Wu CJ, Vago L, Becher B, Köhler N, Wertheimer T, Kuchroo VK, Zeiser R.
    J Clin Invest; 2024 Jun 25; 134(16):. PubMed ID: 38916965
    [Abstract] [Full Text] [Related]

  • 4. Vδ2 T cell subsets, defined by PD-1 and TIM-3 expression, present varied cytokine responses in acute myeloid leukemia patients.
    Wu K, Feng J, Xiu Y, Li Z, Lin Z, Zhao H, Zeng H, Xia W, Yu L, Xu B.
    Int Immunopharmacol; 2020 Mar 25; 80():106122. PubMed ID: 31955066
    [Abstract] [Full Text] [Related]

  • 5. Higher PD-1/Tim-3 expression on IFN-γ+ T cells is associated with poor prognosis in patients with acute myeloid leukemia.
    Huang S, Zhao Y, Lai W, Tan J, Zheng X, Zha X, Li Y, Chen S.
    Cancer Biol Ther; 2023 Dec 31; 24(1):2278229. PubMed ID: 37962843
    [Abstract] [Full Text] [Related]

  • 6. T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment.
    Schnorfeil FM, Lichtenegger FS, Emmerig K, Schlueter M, Neitz JS, Draenert R, Hiddemann W, Subklewe M.
    J Hematol Oncol; 2015 Jul 30; 8():93. PubMed ID: 26219463
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT.
    Noviello M, Manfredi F, Ruggiero E, Perini T, Oliveira G, Cortesi F, De Simone P, Toffalori C, Gambacorta V, Greco R, Peccatori J, Casucci M, Casorati G, Dellabona P, Onozawa M, Teshima T, Griffioen M, Halkes CJM, Falkenburg JHF, Stölzel F, Altmann H, Bornhäuser M, Waterhouse M, Zeiser R, Finke J, Cieri N, Bondanza A, Vago L, Ciceri F, Bonini C.
    Nat Commun; 2019 Mar 25; 10(1):1065. PubMed ID: 30911002
    [Abstract] [Full Text] [Related]

  • 10. RepSox slows decay of CD34+ acute myeloid leukemia cells and decreases T cell immunoglobulin mucin-3 expression.
    Jajosky AN, Coad JE, Vos JA, Martin KH, Senft JR, Wenger SL, Gibson LF.
    Stem Cells Transl Med; 2014 Jul 25; 3(7):836-48. PubMed ID: 24855276
    [Abstract] [Full Text] [Related]

  • 11. Highly proliferative and functional PD-1+ and TIM-3+ T cells are transiently increased in multiple myeloma following autologous hematopoietic stem cell transplantation.
    Batorov EV, Aristova TA, Pronkina NV, Sergeevicheva VV, Sizikova SA, Ushakova GY, Shevela EY, Ostanin AA, Chernykh ER.
    Int Immunopharmacol; 2021 Nov 25; 100():108093. PubMed ID: 34474273
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Scrutinizing the Expression and Blockade of Inhibitory Molecules Expressed on T Cells from Acute Myeloid Leukemia Patients.
    Abdolmaleki M, Mojtabavi N, Zavvar M, Vaezi M, Noorbakhsh F, Nicknam MH.
    Iran J Allergy Asthma Immunol; 2018 Jun 25; 17(3):265-273. PubMed ID: 29908544
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines.
    Liu J, Zhang S, Hu Y, Yang Z, Li J, Liu X, Deng L, Wang Y, Zhang X, Jiang T, Lu X.
    J Immunother; 2016 May 25; 39(4):171-80. PubMed ID: 27070448
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K, Nishida T, Asano-Mori Y, Oshima K, Ohashi K, Mori T, Kanamori H, Miyamura K, Kato C, Kobayashi N, Uchida N, Nakamae H, Ichinohe T, Morishima Y, Suzuki R, Yamaguchi T, Fukuda T.
    Biol Blood Marrow Transplant; 2015 Nov 25; 21(11):2008-16. PubMed ID: 26211985
    [Abstract] [Full Text] [Related]

  • 19. Increased TOX expression concurrent with PD-1, Tim-3, and CD244 expression in T cells from patients with acute myeloid leukemia.
    Huang S, Liang C, Zhao Y, Deng T, Tan J, Zha X, Li Y, Chen S.
    Cytometry B Clin Cytom; 2022 Mar 25; 102(2):143-152. PubMed ID: 34913594
    [Abstract] [Full Text] [Related]

  • 20. Functional exhaustion of CD4+ T cells induced by co-stimulatory signals from myeloid leukaemia cells.
    Ozkazanc D, Yoyen-Ermis D, Tavukcuoglu E, Buyukasik Y, Esendagli G.
    Immunology; 2016 Dec 25; 149(4):460-471. PubMed ID: 27565576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.